Inference in group sequential designs with causal mechanisms: implications for power and mediation analysis

具有因果机制的组序贯设计中的推断:对功效和中介分析的影响

阅读:1

Abstract

BACKGROUND: Group sequential designs are increasingly employed to allow trials to stop early with statistical rigor. While existing work focuses on intention-to-treat effect on clinical endpoints, the properties of mediation analysis (commonly conducted in psychological trials to understand a causal mechanism) remain unknown under group sequential designs. METHODS: Considering a group sequential design with one interim analysis for early stopping for efficacy, we conduct a simulation study to evaluate existing analysis techniques when the treatment effect on a continuous outcome is partially or fully mediated by a continuous intermediate variable measuring a casual mechanism. We study the probability of rejecting the null hypotheses on the total effect (i.e., intention-to-treat effect), direct effect and indirect effect, respectively. We examine the bias of maximum likelihood estimator for these effects. We investigate if the penalized (and conditional) maximum likelihood estimator has smaller bias than the maximum likelihood estimator when a trial stopped (did not stop) early. RESULTS: The presence of an intermediate variable reduces the power of a group sequential design when sample size calculation ignores the causal mechanism, though type I error control remains unaffected. The maximum likelihood estimator is unbiased only for the mediator-outcome path, impacting the properties of mediation analysis since existing methods typically rely on it to estimate the pathways. The penalized maximum likelihood estimator for other pathways has similar bias to the stage-one maximum likelihood estimator, while the conditional maximum likelihood estimator shows negligible or smaller bias than the usual maximum likelihood estimator for estimating the total and the direct effects only. CONCLUSIONS: Mediation analysis needs additional consideration in group sequential designs. As with fixed trial designs, the sample size calculation of group sequential designs should account for the total variability underlying a causal mechanism when the treatment effect is hypothesized to be mediated by an intermediate variable, or risk the overall power to detect an intention-to-treat (total) effect being lower than the nominal value. We suggest reporting several estimators and acknowledging that they may be biased for some mediation pathways. More research is needed to develop methods for the analysis of indirect effect under group sequential designs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。